| Literature DB >> 33804280 |
Norah Salem Alsaiari1, Khadijah Mohammedsaleh M Katubi1, Fatimah Mohammed Alzahrani1, Saifeldin M Siddeeg2,3, Mohamed A Tahoon2,4.
Abstract
Antibiotics can accumulate through food metabolism in the human body which may have a significant effect on human safety and health. It is therefore highly beneficial to establish easy and sensitive approaches for rapid assessment of antibiotic amounts. In the development of next-generation biosensors, nanomaterials (NMs) with outstanding thermal, mechanical, optical, and electrical properties have been identified as one of the most hopeful materials for opening new gates. This study discusses the latest developments in the identification of antibiotics by nanomaterial-constructed biosensors. The construction of biosensors for electrochemical signal-transducing mechanisms has been utilized in various types of nanomaterials, including quantum dots (QDs), metal-organic frameworks (MOFs), magnetic nanoparticles (NPs), metal nanomaterials, and carbon nanomaterials. To provide an outline for future study directions, the existing problems and future opportunities in this area are also included. The current review, therefore, summarizes an in-depth assessment of the nanostructured electrochemical sensing method for residues of antibiotics in different systems.Entities:
Keywords: antibiotics; biosensors; electrochemistry; environment; nanomaterials
Year: 2021 PMID: 33804280 PMCID: PMC8000799 DOI: 10.3390/mi12030308
Source DB: PubMed Journal: Micromachines (Basel) ISSN: 2072-666X Impact factor: 2.891
The different electrochemical techniques used for sensing antibiotics.
| Method | Principle | Limit of Detection | Applications |
|---|---|---|---|
| Electrochemical impedance spectroscopy | Small-amplitude sinusoidal AC excitation signal is applied to measure the resistive properties | 10−12 M | Study of antigen-antibodies reaction, corrosion, and electron transfer kinetics |
| Chronoamperometry | The stepped potential is applied and the current measured | 10−5 M | Measure electrode process mechanism, working electrode surface area, and analytes diffusion coefficient |
| Stripping technique | Worked electrode carries the pre-concentrated analyte then analyte stripped by application of scan potential from the electrode | 10−9 M | Detection of trace elements |
| Square wave voltammetry | Current is determined as a consequence of square wave potential superposed on staircase waveform | 10−8 M | Detection of trace elements, the study of catalytic homogeneous chemical reactions, and electrode kinetics |
| Differential Pulse voltammetry | Current is determined as a function of applied voltage superposed as regular voltage pulses superposed on the potential linear sweep or stair steps | 10−7 M | Detection of trace elements |
| Linear Sweep Voltammetry | Voltage is applied then the current measured on the working electrode surface | 10−5 M | Determination of analytes concentrations, unknown reactions, and irreversible reactions |
| Cyclic Voltammetry | Voltage is applied then the current measured on the working electrode surface | 10−5 M | Assessment of reaction products, trace reaction intermediates, and study redox reactions |
Figure 1Electrochemical immunosensor basic analytical principle. Reproduced from MDPI [47].
Figure 2Classical methods of nanoparticle synthesis. Reproduced from MDPI [51].
Figure 3Metal-organic frameworks (MOFs) synthesis by mixing clusters and metal ions with organic linkers for the production of a cross-linked network. Reproduced from MDPI [60].
Figure 4Methylene blue (MB)/anti-tetracycline (TET) aptamer/DpAu/glassy carbon electrode (GCE) immunosensor fabrication process (a), cyclic voltammograms (CVs) of different modification processes of GCE (b), scanning electron microscope (SEM) image of dispersed AuNPs over GCE (c), aptasensor specificity in the presence of different interferences (d). Reproduced from ESG [71].
Figure 5Design workflow (A), and possible functionalization (B) of magnetic nanomaterials. Reproduced from MDPI [85].
Figure 6TET/Apt/Fe3O4/ionic liquid (IL)/screen-printed electrode (SPE) Aptasensor fabrication process (a), cyclic voltammograms of the aptasensor toward different concentrations of tetracycline (1.0 to 108 nM) (b). Reproduced from ESG [89].
Antibiotics electrochemical sensors based on nanomaterials and their composites.
| Electrode | Interface | Transduction Method | Antibiotics Detected | Limit of Detection (nM) | Selectivity | Real Samples | Ref. |
|---|---|---|---|---|---|---|---|
| Au | QD–cDNA2/cDNA1/ | SWASV | Tetracycline, chloramphenicol, and streptomycin | 20, 5, and 10, respectively | - | Milk | [ |
| GCE | Dendritic probe encoded with magnetic aptamer QDs | SWV | chloramphenicol | 0.001 | Oxytetracycline and kanamycin | Fish | [ |
| GCE | PoAP/GQD | LSV | Levofloxacin | 10 | Norfloxacin, lomefloxacin, enrofloxacin, and ciprofloxacin. | Milk | [ |
| GCE | CdS QDs | DPASV | Ciprofloxacin | 23 | Gentamycin, erythromycin, kanamycin, chloramphenicol, and ofloxacin, | Human urine | [ |
| Au | Ce-MOF@COF | EIS | Oxytetracycline | 0.000036 | Kanamycin, streptomycin sulfate, doxycyclinehyclate, bleomycin, and ampicillin | Urine, water, and milk | [ |
| GCE | Y-DNA-NMOF | SWV | Oxytetracycline, and chloramphenicol | 0.000049, and 0.000034, respectively | gentamicin | Milk | [ |
| GCE | NMOF Probe labeled with magnetic aptamer | SWV | Kanamycin and oxytetracycline | 0.00016, and 0.00019, respectively | Gentamicin sulfate, doxycycline, streptomycin, chloramphenicol, and Chlortetracycline | Milk | [ |
| GCE | Aptamer-metal ions NMOF Biocodes | SWV | Chloramphenicol and kanamycin | 0.00020, and 0.00017, respectively | metal ions (K, Ca, Mg), oxytetracycline, and chlortetracycline | Milk | [ |
| GCE | MIL-101(Cr)/XC-72 | DPV | Chloramphenicol | 1.6 | Amikacin, gentamicin, neomycin, rutin, quercetin, penicillin, kanamycin, kitasamycin, tetracycline, and chlortetracycline | Milk, eye drop, and honey | [ |
| Au | MMOF-MIP | LSV | Tetracycline | 0.00000023 | Doxycycline | Honey | [ |
| GCE | CoFe2O4@CdSe capped with PVP | SWV | Rifampicin | 0.00000005 | Glucose, L-threonine, uric acid, pyrazinamide, and isoniazid | Pharmaceutical drug and serum | [ |
| GCE | NiFe2O4-MWCNTs | CV | Cefixime | 19 | Ascorbic acid, glucose, tartaric acid, CO3−2, SO4−2, NH4+, and Ca+2 | Plasma, urine, and tablets | [ |
| CE | MMIP/CE | DPV and CV | Kanamycin | 0.03 | Erythromycin, streptomycin, and gentamycin | Milk and animal food derivatives | [ |
| SPCE | MIP decorated Fe3O4 | EIS | Sulfamethoxazole | 0.002 | Sulfacetamide and sulfadiazine | Seawater | [ |
| GCE | Aptamer/NP-PtTi/ | DPV | Streptomycin | 0.02 | Streptomycin, neomycin sulfate, kanamycin sulfate, and terramycin | Milk | [ |
| MBCPE | Fe3O4 NPs@OA/antiTET | EIS | Tetracycline | 0.000004 | Doxycycline and oxytetracycline | Serum, honey, milk, and drugs | [ |
| SPE | Fe3O4/IL | CV | Tetracycline | 1.00 | - | Milk | [ |
| Au | Ab-MNPs-chitosan | DPV | Tetracycline | 0.08 | Chloramphenicol, penicillin, gentamycin, and erythromycin | Milk | [ |
| GCE | TH-GS/GA/ | SWV | Kanamycin | 0.04 | Neomycin, gentamicin, vitamin C, and glucose | Animal foods | [ |
| GCE | Pt NPs/C | DPV | Tetracycline | 4281 | - | Human urine | [ |
| GCE | Pt Nps/MWCNT | LSV | Ceftriaxone | 9.02 | Lidocaine | Human serum | [ |
| GCE | MIP/Ag@Au Nps/Ils | DPV | Ceftizoxime | 0.003 | Dopamine and ascorbic acid | Pharmaceuticals | [ |
| GCE | Fe3O4-CMC@Au | SWV | Chloramphenicol | 67.00 | Ca+2, glucose, xanthine, cysteine, uric acid, and ascorbic acid | Urine | [ |
| CPE | GNPs/MWCPE | SWV | Cefixime | 4.00 | Caffeine, glucose, oxalic acid, uric acid, citric acid, and ascorbic acid, | Tablets and human urine | [ |
| ME | gold colloids | CV | Tetracycline | 200 | - | - | [ |
| SPCE | Tyr-AuNPs | Amperometric | Sulfamethoxazole | 22 × 103 | - | Water | [ |
| Graphite SPE | HEM/Apt/AuNPs/ | DPV | Chloramphenicol | 5.00 | Florfenicol, amoxicillin, cephalexin, and cefixime | Blood serum | [ |
| Interdigitated | Aptamer/AuNCs-Cys | SWV | Chloramphenicol | 5.00 | Florfenicol, amoxicillin, cephalexin, cefixime, and chloramphenicol | Human serum | [ |
| GCE | MB/Anti-TET/AuNps | CV | Tetracycline | 0.005 | Gentamycin sulfate, kanamycin monosulfate, and oxytetracycline hydrochloride | Milk | [ |
| MIP/NPAMR | MIP/NPAMR | CV | Metronidazole | 0.00003 | Dimetridazole, 4 | Tablets and fish tissues | [ |
| SPE | Aptamer/poly-DPB/ | LSV | Kanamycin | 9.5 | Sulfadimethoxine, tetracycline, ampicillin, streptomycin, and neomycin | Milk | [ |
| GCE | AuNPs/poly TTBA/ | DPV | Daunomycin | 0.053 | Adriamycin, anthraquinone, neomycin, chloramphenicol, kanamycin, and tetracycline | Human urine | [ |
| GCE | SGN-hematein/ILs/ | DPV | Penicillin | 0.0002 | Levofloxacin | Milk | [ |
| GCE | Au/N-G | EIS and LSV | Chloramphenicol | 591.0 | Chlortetracycline, Oxytetracycline, and Metronidazole | Eye drop | [ |
| GCE | Graphene | LSV | Midecamycin | 101.0 | Isovalerylspiramycin, acetylspiramycin, josamycin, and Kitasamycin | Urine and serum samples | [ |
| GCE | Au/C3N4/GN | SWV | Ciprofloxacin and Chloramphenicol | 421.0 and 28.0 | - | Milk | [ |
| GCE | Anti-Kan/WGS/PBCTS/NPG | SWV | Kanamycin | 0.014 | Neamine, neomycin, and gentamicin | Pork meat | [ |
| GCE | β-cyclodextrin/rGO | DPV | Gatifloxacin | 21.0 | Norfloxacin, ofloxacin, ciprofloxacin, and moxifloxacin | Pharmaceuticals, and human urine | [ |
| GCE | PoAP/GQD | DPV | Levofloxacin | 11.0 | Norfloxacin, lomefloxacin, enrofloxacin, and ciprofloxacin | Milk | [ |
| GCE | Cl-RGO | DPV | Chloramphenicol | 1000 | Tetracycline, Erythromycin, penicillin G, and | Eye drops, water, calf plasma, and milk | [ |
| GCE | CO3O4@rGO | Chronoamperometry and DPV | Chloramphenicol | 551.0 | glutathione, cysteine, and uric acid | Honey and milk | [ |
| GCE | GO/ZnO | DPV | Chloramphenicol | 11.0 | 4-amino phenol, 4-nitro phenol, 4-nitroaniline, 4-nitrobenzene, Cl-, and Ca+2 | Eye drops, milk, and honey | [ |
| GCE | PPy3C/ERGO | DPV | Streptomycin | 0.6 | Gentamycin, kanamycin, amikacin, neomycin, and dihydrostreptomycin | Honey and porcine kidney | [ |
| GCE | 3D RGO | DPV | Chloramphenicol | 151.0 | uric acid, cysteine, taurine, and glutathione | Milk and eye drops | [ |
| GCE | MIP/G-AuNPs | DPV | Levofloxacin | 531.0 | Norfloxacin, prulifloxacin, oxytetracycline, and chlortetracycline | Levofloxacin capsule | [ |
| GCE | Aptamer/HNP–PtCu/ | DPV | Kanamycin | 0.0009 | Human chorionic gonadotropin, tyrosine, dopamine, TSH hormone. | Chicken | [ |
| GCE | Au-Pt Nps/MWCNT | LSV | Cefotaxime | 1.0 | Glucose, dopamine, and ascorbic acid | Plasma | [ |
| Au | ssDNA/SWCNT | SWV | Levofloxacin | 75.0 | - | Urine | [ |
| GCE | 3DCNTs@ Cu | CV | Chloramphenicol | 10 × 103 | Florfenicol, clindamycin, Dansyl chloride, and thiamphenicol | Milk | [ |
| Au | MIPs/GR-MWCNTs/ | Amperometry, and CV | Neomycin | 7.65 | Erythromycin, kanamycin, streptomycin, and | Honey and milk | [ |
| GCE | MWCNT-GNPs/MIP | CV | Tetracycline | 91.0 | Chloramphenicol, nafcillin, and oxytetracycline | - | [ |
| Au | ssDNA/AuNPs/en/ | CV | Valrubicin | 19.0 | K+, paracetamol, Na+, glucose, urea, azithromycin, ascorbic acid, and Caffeine | Blood and human urine | [ |
| GCE | MWCNT-CTAB-PDPA | Stripping DPV | Chloramphenicol | 3.0 | Streptomycin, ceftazidime, cefotaxime, and ceftizoxime | Honey and milk | [ |
| Paraffin | MWCNT-Sb Nps | DPV | Trimethoprim, and Sulfamethoxazole | 32.0 and 25.0 | Carbaryl, and 17β Estradiol | Natural H2O | [ |
| GCE | AgNPs/MWCNTsCOOH | DPV | Adriamycin | 1.80 | - | Ct-DNA | [ |
| GCE | Anti-TET/GA/(CS-PBGR)2/MWCNTs-CS | DPV | Tetracycline | 0.006 | Gentamycin sulfate, kanamycinmonosulfate, and oxytetracycline | Milk | [ |
| GCE | Anti-TET/MWCNTs | DPV | Tetracycline | 6.0 | Doxycycline | Milk | [ |
| GCE | Si–Fe/NOMC/GCE | DPV | Chloramphenicol | 31.0 | Florfenicol, benzylpenicillin potassium, chlortetracycline hydrochloride, gentamicin sulfate, and thiamphenicol | Eye drop | [ |
| GCE | CS @MnO2 | DPV | Chlortetracycline | 261.0 | Rifampicin, Oxytetracycline, and chloramphenicol | Fish, shrimp, and milk | [ |
| GCE | CB-DHP | SWV | Amoxicillin | 121.0 | Humic acid, vermicompost, albumin, glucose, K+, and Na+ | Water and urine | [ |
| SPE | CdS-KAP+ PbS-STP/ | DPV | Streptomycin and kanamycin | 0.05 and 0.09 | Oxytetracycline, tobramycin, neomycin, and gentamycin | Milk | [ |
| GCE | Aptamer/ | EIS | Tobramycin | 0.02 | Doxycycline, oxytetracycline, and Kanamycin | Human serum and urine | [ |
| GCE | Aptamer/Fe3O4@mC | EIS | Oxytetracycline | 0.00006 | Chlortetracycline, doxycycline, and tetracycline | Milk | [ |
| GCE | Nanodiamonds | SWV | Pyrazinamide | 221.0 | - | Human serum and urine | [ |
| GCE | STR Aptamer/GRFe3O4-AuNPs/PCNR | DPV | Streptomycin | 0.05 | Glucose, methionine, ascorbic acid, and penicillin | Milk | [ |